Clinical Trial: A Phase 1b Study of Imvotamab in Moderate to Severe Rheumatoid Arthritis
Study Status: Completed
Recruit Status: RECRUITING
Condition: Rheumatoid Arthritis
Study Type: INTERVENTIONAL
Official Title: A Phase 1b, Randomized, Placebo-controlled, Multicenter Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Imvotamab in Participants With Moderate to Severe Rheumato
Brief Summary:
The purpose of this study is to determine the safety and tolerability of imvotamab in patients with moderate to severe rheumatoid arthritis who have failed prior therapies.Participants will be given imvotamab or placebo through a vein (i.e., intravenously).A placebo is a look-alike substance that contains no active drug
Read more